Glowing dye could help surgeons remove all cancer in one go
NCT ID NCT04752137
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if a special dye called indocyanine green (ICG) can help surgeons see the edges of bone or soft tissue tumors during surgery. About 100 adults with benign or malignant masses will receive the dye before their tumor is removed. The goal is to see if using the dye leads to cleaner removal and lowers the chance of the tumor coming back within 2 years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may one day personalize drug dosing after stem cell transplants
- New imaging agent aims to sharpen cancer detection
- Could a daily pill tame rare cancers in teens? new trial investigates
- Could your genes hold the key to cancer risk? scientists investigate families
- Cancer patients get help planning families in new study
- New hope for kids with resistant cancers: targeted drug enters trial